Significant Ownership of Ph.D. Noubar B. Afeyan
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Ph.D. Noubar B. Afeyan focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Cambridge, MA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
Follow Filing Activity
Follow Ph.D. Noubar B. Afeyan and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Ph.D. Noubar B. Afeyan
Significant Ownership of Ph.D. Noubar B. Afeyan
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OMGAQ | OMEGA THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 53% | $1,461,279 | -$336,554 | 29,225,579 | 0% | Noubar Afeyan | 03 Feb 2025 |
| OMGAQ | OMEGA THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 53% | $1,461,279 | 29,225,579 | Noubar Afeyan | 29 Dec 2024 |
Schedules 13D/G Reported by Ph.D. Noubar B. Afeyan:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.